Skip to main content

Table 5 Optimal HCV-derived HLA class I restricted CTL epitopes

From: Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"

Protein

HLA Restriction

Sequence

Position

Reference

Core

B60

GQIVGGVYLL

28–37

[67]

Core

A0201

YLLPRRGPRL

35–44

[68]

Core

B7

GPRLGVRAT

41–49

[69]

Core

B44

NEGCGWAGW

88–96

[70]

Core

A0201

DLMGYIPLV

132–140

[71]

Core

A0201

ALAHGVRAL

150–158

[15]

Core

A0201

LLALLSCLTV

178–187

[72]

Core

A11

MSTNPKPQK

1–9

[73]

P7

A29

FYGMWPLLL

790–798

[15]

P7

Cw7

FYGMWPLL

790–797

[15]

E1

A0201

ILHTPGCV

220–227

[74]

E1

B35

NASRCWVAM

234–242

[25]

E1

A0201

QLRRHIDLLV

257–266

[74]

E1

A23

FLVGQLFTF

285–293

[15]

E1

A0201

MMMNWSPTT

322–330

[15]

E1

A0201

SMVGNWAKV

363–371

[74]

E1

B35

CPNSSIVY

207–214

[15]

E2

A0201

SLLAPGAKQNV

401–411

[74]

E2

B53

CRPLTDFDQGW

460–469

[69]

E2

B51

YPPKPCGI

489–496

[73]

E2

B60

GENDTDVFVL

530–539

[75]

E2

B50

CVIGGAGNNT

569–578

[73]

E2

A0201

RLWHYPCTV

614–622

[76]

E2

A11

TINYTIFK

621–628

[69]

E2

B60

LEDRDRSEL

654–662

[75]

E2

A2402

EYVLLLFLL

717–725

[77]

E2

B57

NTRPPLGNWF

541–550

[15]

NS2

A29

MALTLSPY

827–834

[25]

NS2

A25

SPYYKRYISW

832–841

[78]

NS2

A23

YISWCLWWL

838–845

[69]

NS3

A24

AYSQQTRGL

1031–1039

[79]

NS3

A0201

CINGVCWTV

1073–1081

[68]

NS3

A0201

LLCPAGHAV

1169–1177

[68]

NS3

A0201

LLCPSGHAV

1169–1177

[68]

NS3

A11

TLGFGAYMSK

1261–1270

[80]

NS3

A0201

ATLGFGAYM

1260–1268

[81]

NS3

A0201

TLHGPTPLL

1617–1625

[81]

NS3

A0201

TGAPVTYSTY

1287–1296

[79]

NS3

A2402

TYSTYGKFL

1292–1300

[77]

NS3

B35

HPNIEEVAL

1359–1367

[82]

NS3

B8

HSKKKCDEL

1395–1403

[69]

NS3

A0201

KLVALGINAV

1406–1415

[68]

NS3

B8

LIRLKPTL

1611–1618

[75]

NS3

A11

TLTHPVTK

1636–1643

[80]

NS3

A68

HAVGLFRAA

1175–1184

[15]

NS3

A0201

GLLGCIITSL

1038–1047

[81]

NS4

A2402

FWAKHMWNF

1760–1768

[77]

NS4

B35

IPDREVLY

1695–1712

[15]

NS4

A24

VIAPAVQTNW

1745–1754

[15]

NS4

B57

LTTSQTLLF

1801–1809

[15]

NS4B

A25

EVIAPAVQTNW

1744–1754

[78]

NS4B

A25

ETFWAKHMW

1758–1766

[78]

NS4B

A0201

SLMAFTAAV

1789–1797

[68]

NS4B

A0201

LLFNILGGWV

1807–1816

[72]

NS4B

A0201

ILAGYGAGV

1851–1859

[72]

NS4B

B37

SECTTPCSGSW

1966–1976

[78]

NS4B

B38

AARVTAIL

1941–1948

[75]

NS5

A2

VLSDFKTWL

1987–1995

[83]

NS5

B35

EPEPDVAVL

2162–2170

[15]

NS5

B57

LGVPPLRAWR

2912–2921

[15]

NS5A

B60

HEYPVGSQL

2152–2160

[75]

NS5A

B35

PCEPEPDVAVL

2161–2171

[75]

NS5A

B38

NHDSPDAEL

2218–2226

[75]

NS5A

A2

SPDAELIEANL

2221–2231

[75]

NS5A

A25

ELIEANLLW

2225–2233

[78]

NS5A

A0201

ILDSFDPLV

2252–2260

[68]

NS5A

B60

REISVPAEIL

2267–2275

[80]

NS5B

A3

SLTPPHSAK

2510–2518

[80]

NS5B

A3

RVCEKMALY

2588–2596

[69]

NS5B

A2

ALYDWTKL

2594–2602

[78]

NS5B

B57

KSKKTPMGF

2629–2637

[80]

NS5B

A0201

GLQDCTMLV

2727–2735

[72]

NS5B

B38

HDGAGKRVYL

2794–2804

[80]

NS5B

A25

TARHTPVNSW

2819–2828

[78]

NS5B

A2402

RMILMTHFF

2841–2849

[77]

NS5B

A2402

CYSIEPLDL

2870–2878

[77]

NS5B

A31

VGIYLLPNR

3003–3011

[80]